ViiV Healthcare Commits $100M Over Three Years Under Its U.S. Positive Action Program To Support Local HIV Organizations

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced a $100 million, three-year commitment through its U.S. Positive Action program, to provide sustained support to community organizations delivering HIV prevention and treatment services and advocacy; strengthen the navigators and referral networks that help people connect to and remain in care; and provide flexible funding to address emerging gaps in access in communities most impacted by HIV.